Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:acquiredBy |
Biosynex
|
| gptkbp:acquisitionYear |
2023
|
| gptkbp:foundedYear |
1985
|
| gptkbp:headquartersLocation |
Medford, New York, United States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Chembio Diagnostics
|
| gptkbp:industry |
medical diagnostics
|
| gptkbp:notableProduct |
DPP COVID-19 System
HIV rapid tests |
| gptkbp:publiclyTraded |
true
|
| gptkbp:specializesIn |
infectious disease detection
point-of-care diagnostic tests |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
CEMI
|
| gptkbp:website |
https://chembio.com
|
| gptkbp:bfsParent |
gptkb:John_Sperzel
|
| gptkbp:bfsLayer |
7
|